Chronic Kidney Disease and GLP-1 RAs

Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.

Conversation around current considerations for use of GLP-1 RAs in people with type 2 diabetes and chronic kidney disease (CKD). The discussion will include general considerations for management of diabetes in CKD, potential benefits of GLP-1 RA therapy in CKD (e.g., glycemic lowering, CV risk reduction, potential kidney benefits), and a discussion of contemporary guideline recommendations for GLP-1 RA use in this population.

Claim CE and MOC Credit at https://bit.ly/4aNc3t8

Recommended Videos
Advancements in the Treatment of Kawasaki Disease
Key Diagnostic Points from the Kawasaki Disease Statement
Future Directions of Kawasaki Disease
Acute and Long Term Imaging Management for Kawasaki Disease
Updates on Echocardiograms for Measurements of the Coronary Artery in Pati...
saved video
Save Video

Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.

See Full Content
Video is not available. Please check the URL.